ha 1004 has been researched along with potassium chloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, PJ; Sybertz, EJ; Tetzloff, G | 1 |
| Clegg, JM; McKenna, TM; Williams, TJ | 1 |
2 other study(ies) available for ha 1004 and potassium chloride
| Article | Year |
|---|---|
A post-calcium site of action for HA1004, a novel vasculorelaxant.
Topics: Animals; Aorta; Biological Transport; Calcium; Drug Interactions; Isoquinolines; Male; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Rabbits; Sulfonamides; Vasodilator Agents; Verapamil | 1986 |
Protein kinase C is a mediator of lipopolysaccharide-induced vascular suppression in the rat aorta.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amino Acid Oxidoreductases; Animals; Aorta; Arginine; Cell Membrane; Citrulline; Cycloheximide; Cytosol; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Kinetics; Lipopolysaccharides; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phorbol 12,13-Dibutyrate; Piperazines; Potassium Chloride; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley; Stereoisomerism; Sulfonamides | 1994 |